Sign Up to like & get
recommendations!
0
Published in 2019 at "Neurology and Therapy"
DOI: 10.1007/s40120-019-00150-x
Abstract: Intravenous levetiracetam (IV LEV) is approved for treatment status epilepticus (SE). However, the drug’s high cost must be considered when deciding on a treatment strategy. This study aimed to compare the efficacy of brand-name and…
read more here.
Keywords:
brand name;
seizure;
generic lev;